Northwestern Mutual Wealth Management’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
PCM
NIM
FHA
AAM
1WA
Northwestern Mutual Wealth Management's HQL Position: Q2 2026 in Review
Northwestern Mutual Wealth Management increased its abrdn Life Sciences Investors (HQL) stake by 4% in Q2 2026, buying an estimated $795 and bringing the position to 1,168 shares worth $23.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2810.
Northwestern Mutual Wealth Management first reported a position in HQL in Q4 2015 and has held it in 15 quarters since. The position peaked at $51K in Q4 2023. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.
- Northwestern Mutual Wealth Management held 1,168 shares of abrdn Life Sciences Investors worth $23.4K as of Q2 2026.
- Northwestern Mutual Wealth Management bought 45 abrdn Life Sciences Investors shares in Q2 2026, an estimated $795.
- abrdn Life Sciences Investors made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2810 holding.
- Northwestern Mutual Wealth Management first reported a position in abrdn Life Sciences Investors in Q4 2015 and has held it in 15 quarters since.
- Northwestern Mutual Wealth Management's abrdn Life Sciences Investors position peaked at $51K in Q4 2023.
- 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.